Mathew G Angelos

8PUBLICATIONS
108CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 24, 2026
A Phase 1/1b Study of the All-Oral Regimen CC-486 and Venetoclax in Acute Myeloid Leukemia.

|Feb 13, 2026
Tolerability and Outcomes With Serial Cycles of 28 Days of Venetoclax in Newly Diagnosed Patients With Acute Myeloid Leukemia.

Michael K Jones, Jesse Sanchez, Megan Connor

|Jan 06, 2026
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies.

Alberto Carturan, Mathew G Angelos, Puneeth Guruprasad

|Apr 08, 2025
The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and Application.

Anne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas

|Dec 03, 2024
The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application.

Anne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas

|Jul 19, 2024
CD5 deletion enhances the antitumor activity of adoptive T cell therapies.

Ruchi P Patel, Guido Ghilardi, Yunlin Zhang

Pageof 2

Frequent Collaborators

4 joint publications

Marco Ruella

2 joint publications

Raymone Pajarillo

2 joint publications

Patrizia Porazzi

2 joint publications

Antonia Rotolo